Becton, Dickinson and Company BDX
Annual report 2024
added 11-27-2024
Country |
USA |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
CEO |
Mr. Thomas Polen |
Employees in the company |
72 000 |
Shares |
290 M |
Market Cap[1] |
$ 64.4 B |
EBITDA (LTM) |
$ 3.98 B |
P/E (LTM) |
40.21 |
P/S (LTM) |
3.44 |
EPS (LTM) |
5.87 |
Becton, Dickinson and Company is an international company specializing in the development and production of medical devices and technologies for the diagnosis and treatment of various diseases. The company was founded in 1897 in the United States and today is one of the largest manufacturers of medical devices in the world.
BDX offers a wide range of medical devices, including syringes, needles, blood collection systems, microbiological and diagnostic systems, and more. The company also provides training for healthcare professionals, consultations, and support for patients.
The company has offices worldwide and serves patients in more than 190 countries. The headquarters are located in New Jersey, USA.
Becton, Dickinson and Company's goal is to help people lead healthy lifestyles by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.